Single Anastmosis Gastric Bypass as a Management of Diabetes Mellitus

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is a global public health issue. The global prevalence of diabetes among adults 20~79 years of age was 8.3% in 2011, with 366 million people affected, and was predicted to increase to 9.9% by 2030. T2DM is considered to be an irreversible, chronic, and progressive disease. In spite of the rapid progress in pharmacological and non-pharmacological approaches to diabetes in recent years, 92.7% of adult diabetic patients had poorly-controlled blood glucose levels and related comorbidities. Aim of the Study: It is to review the result of Single Anastomosis Gastric Bypass as surgical treatment of Diabetes Mellitus. Methodology: The rates of obesity are expanding with no less than 300 million individuals overall now are obese. Obesity is associated with decreased life expectancy, increased morbidity and mortality, and greater healthcare costs. Conclusion: The advantage of the OAGB is its relative simplicity, compared to the RY gastric bypass. The single anastomosis results in a shorter operating time and less operative complications. Long term, the OAGB, results in fewer intestinal obstruction problems and less risk for internal herniation. As stated above, over the long-term, an OAGB usually brings about better weight loss and a higher diabetes resolution rate than a RYGB. Keywords: Single Anastmosis, Gastric Bypass, Diabetes Mellitus